About US
Contact us
-
Hospira returning to market with sedative propofolHospira's ($HSP) inability to provide propofol has been one reason the sedative has been on shortage lists for some time. Now, Hospira says it should be back in the market with a significant supply b2012/11/12
-
CVS shucking more drugs from its coverage listBeginning in January, the list of drugs CVS Caremark's ($CVS) pharmacy-benefit business will refuse to cover will grow to about 50. The company is adding 17 drugs to nearly three dozen it already2012/11/12
-
GSK, XenoPort part ways after Horizant disappointmentGlaxoSmithKline ($GSK) is punting on Horizant. The U.K.-based drugmaker is kicking the restless legs syndrome drug back to partner XenoPort after a series of setbacks, including disappointing sales2012/11/9
-
Sanofi halves the cost of controversial new cancer drug ZaltrapSanofi ($SNY) has put Zaltrap on sale for 50% off. The colorectal cancer drug isn't an overstock, but a brand-new product, approved by FDA in August. Like most new cancer drugs these days, it's expe2012/11/9
-
Obama's re-elected. So what's next for pharma?To call the 2012 election a referendum on Obamacare would be reductionist. But the Affordable Care Act's survival is, no question, the most obvious and specific consequence of President Obama's re-2012/11/8
-
Lundbeck earnings undercut by Lexapro declineDanish drugmaker Lundbeck, whose Lexapro sales have been depressed by generics, managed to maintain a flat operating profit in its third quarter as it works on a potential new blockbuster in hopes2012/11/8
-
Pfizer nabs FDA blessing for blockbuster hopeful XeljanzIt's a banner day for Pfizer ($PFE): The drugmaker's new rheumatoid arthritis drug tofacitinib, one of its leading hopes for sales growth, finally won its approval from the FDA. Now dubbed Xeljanz,2012/11/7
-
Drug offers new pain management therapy for diabeticsA study from the University of Calgary's Hotchkiss Brain Institute shows there is evidence to support a new drug therapy called nabilone to treat diabetic neuropathy, or nerve pain. Researchers enroll2012/11/7
-
FDA backs Pradaxa safety as docs lament lack of antidoteFDA has sifted the data on Pradaxa, the blood thinner that's attracted some controversy of late. And despite an onslaught of adverse-event reports--and hundreds of deaths--the agency says rates2012/11/6
-
Construction to begin on world's largest chromatography labNovasep will build the world's largest chromatography plant for drug development in the French town of Mourenx. Announcing its plans, the life sciences manufacturer said it would put 30 million euros2012/11/6